---
figid: PMC4455348__ajtr0007-0733-f1
figlink: /pmc/articles/PMC4455348/figure/fig01/
number: F1
caption: A schematic of HER3 engagedment in heterodimerization and signaling. General
  features of HER2:HER3 signaling. HER2 fails to bind any known HER-family ligands
  and HER3 has impaired catalytic activity. Following ligand engagement, HER3 engages
  and allosterically activates its kinase partner, in this case HER2. Phosphorylation
  of its C-terminal tail leads to recruitment of adapter proteins leading to activation
  of PI3K and RAS pathways. Activation of PI3K leads to phosphorylation of membrane
  phosphoinositides producing PIP3, which in turn docks the PH domain-containing proteins
  PDK1 and AKT. Membrane-bound AKT is phosphorylated and activated by PDK1 and mTOR.
  Activated AKT proceeds to phosphorylate a plethora of cellular substrates involved
  in diverse biological processes. HER3 ligand neuregulin (NRG) initiates HER2-HER3
  dimerization which also leads to activate epithelial-mesenchymal transition (EMT)
  via phosphorylation of AKT-HSF1 (heat shock factor1)-SLUG (known EMT-regulator)
  signaling pathway (please see the text for details).
pmcid: PMC4455348
papertitle: 'A critical role for HER3 in HER2-amplified and non-amplified breast cancers:
  function of a kinase-dead RTK.'
reftext: Nandini Dey, et al. Am J Transl Res. 2015;7(4):733-750.
pmc_ranked_result_index: '91398'
pathway_score: 0.9452149
filename: ajtr0007-0733-f1.jpg
figtitle: Schematic of HER3 engagedment in heterodimerization and signaling
year: '2015'
organisms:
- Homo sapiens
ndex: 9e862ebe-defc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4455348__ajtr0007-0733-f1.html
  '@type': Dataset
  description: A schematic of HER3 engagedment in heterodimerization and signaling.
    General features of HER2:HER3 signaling. HER2 fails to bind any known HER-family
    ligands and HER3 has impaired catalytic activity. Following ligand engagement,
    HER3 engages and allosterically activates its kinase partner, in this case HER2.
    Phosphorylation of its C-terminal tail leads to recruitment of adapter proteins
    leading to activation of PI3K and RAS pathways. Activation of PI3K leads to phosphorylation
    of membrane phosphoinositides producing PIP3, which in turn docks the PH domain-containing
    proteins PDK1 and AKT. Membrane-bound AKT is phosphorylated and activated by PDK1
    and mTOR. Activated AKT proceeds to phosphorylate a plethora of cellular substrates
    involved in diverse biological processes. HER3 ligand neuregulin (NRG) initiates
    HER2-HER3 dimerization which also leads to activate epithelial-mesenchymal transition
    (EMT) via phosphorylation of AKT-HSF1 (heat shock factor1)-SLUG (known EMT-regulator)
    signaling pathway (please see the text for details).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - AKT1
  - AKT2
  - HSF1
  - AKT3
  - NRG1
  - MAP2K2
  - MTOR
  - ARAF
  - ERBB2
  - MAP2K1
  - BRAF
  - HRAS
  - KRAS
  - NFKB1
  - NFKB2
  - NRG3
  - NRG4
  - MAPK1
  - NRG2
  - SART3
  - GSK3B
  - BAD
  - ERBB3
  - SHC2
  - REL
  - NRAS
  - MAPK3
  - GRB2
  - RELB
  - SNAI2
  - SHC1
  - RELA
  - SHC4
  - SHC3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HSF1
  symbol: HSF1
  source: hgnc_symbol
  hgnc_symbol: HSF1
  entrez: '3297'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG3
  entrez: '10718'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG4
  entrez: '145957'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NRG
  symbol: NRG
  source: bioentities_symbol
  hgnc_symbol: NRG2
  entrez: '9542'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: SLUG
  symbol: SLUG
  source: hgnc_prev_symbol
  hgnc_symbol: SNAI2
  entrez: '6591'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4455348__F1
redirect_from: /figures/PMC4455348__F1
figtype: Figure
---
